FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
October 18, 2021 at 11:52AM
FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ
Welcome to vaccine education 